Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trial
Titel:
Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trial
Auteur:
Modjarrad, Kayvon Scott, Paul T McCauley, Melanie Ober-Shepherd, Brittany Sondergaard, Erica Amare, Mihret F Parikh, Ajay P Omar, Badryah Minutello, Ada-Marie Adhikarla, Haritha Wu, Yukun P, Andrey Rojas Delore, Valentine Mantel, Nathalie Morrison, Meshell N Kourbanova, Kamila S Martinez, Melissa E Guzman, Ivelese Greenleaf, Melissa E Darden, Janice M Koren, Michael A Hamer, Melinda J Lee, Christine E Hutter, Jack N Peel, Sheila A Robb, Merlin L Vangelisti, Manuel Feroldi, Emmanuel